Organovo Holdings, Inc.
ONVO
Pozycja w akcjach
#36000
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Cena akcji
$2.00
Ostatnia synchronizacja: 2025-05-19
Kapitalizacja rynkowa
$2.93M
Zmiana (1 dzień)
-3.38%
Zmiana (1 rok)
656.14%
Kraj
US
Handel Organovo Holdings, Inc. (ONVO)
Kategoria
Healthcare
Historia ceny akcji dla Organovo Holdings, Inc. (ONVO)
Najwyższa cena zamknięcia: $5.13 dnia 2025-03-01
Najniższa cena zamknięcia: $131.45 dnia 2014-11-01
Najniższa cena zamknięcia: $131.45 dnia 2014-11-01
Historia cen akcji firmy Organovo Holdings, Inc. od 2014 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.79 | -3.81% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
